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With great interest I read the recently published work by
Schlenk and colleagues that addressed the controversially
discussed issue of lowering blood glucose levels in patients
suffering from aneurismal subarachnoid hemorrhage [1].
These critically ill patients are at increased risk of developing
secondary brain damage whenever blood glucose levels are
too high or too low.
The authors focused on the initial 12 hours following insulin
administration and showed stable blood glucose concen-
trations with an average of approximately 8 mM. Given a
predefined limit of intervention (140 mg/dl = 7.8 mM), the
administered insulin dose must therefore have been rather
small. Blood glucose appeared stable at least during the
presented 14-hour period, which is also in line with our
observations avoiding lower blood glucose targets as
propagated by van den Berghe and colleagues (4.4–6.1 mM)
[2]. The extracellular glucose decreased significantly by
3 hours following insulin infusion. Schlenk and colleagues
interpret these changes as an increase in cerebral glucose
utilization. This interpretation, however, is difficult to under-
stand since cerebral glucose uptake occurs independently of
insulin and the blood glucose levels remained stable.
The calculated increased lactate/glucose ratio [3] suggests
sustained glycolysis-driven lactate production over time.
Whether this is a consequence of insulin treatment (for which
specific data are missing), is a consequence of underlying
injury with variable degrees of damage, is caused by different
starting time points of insulin administration, is overshadowed
by different degrees of sedation (awake, deep barbiturate
coma, hypothermia), or is overshadowed by varying
penetration depths of the microdialysis probes remains
unclear. In addition, the exact nutritional regimen also needs
to be explained. Addition of these important pieces of
information would help one to draw appropriate conclusions.
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Author’s response
Florian Schlenk and Asita Sarrafzadeh
We are pleased that our work evokes the interest of the
readership. Indeed, avoidance of hypoglycemia is of major
importance in brain-lesioned patients, which explains our
moderate regimen for glycemic control (target range
80–140 mg/dl) [1].
Unexpectedly, 3 hours after insulin onset, the cerebral
glucose decreased despite stable blood levels [1]. The
underlying mechanisms remain unclear, as physiologic
cerebral glucose uptake seems to occur independently of
insulin [4]. Yet insulin receptors are widely spread in
cerebral tissue, and the injured brain might react differently.
The risk of cerebral glucose depletion is stressed by severe
metabolic derangements demonstrated during lowered brain
glucose in traumatic brain injury and subarachnoid hemor-
rhage [5,6].
Cerebral glucose levels can be influenced by various factors,
which cannot all be controlled in a clinical setting.
Interindividual differences as quoted by Dr Stover (catheter
depth or degree of damage and sedation), however, can
hardly explain longitudinal changes over time, and
barbiturates or hypothermia were not applied. Nutrition-
related effects should be mediated by glucose changes,
which were recorded. Ischemia could also widely be
excluded [1], and an increase in the lactate/glucose ratio
without changes in lactate or pyruvate is unspecific and does
not support energetic impairment or hyperglycolysis [5,7].
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Finally, despite using different insulin starting points, we
observed a synchronic effect starting 3 hours after insulin
onset in an analysis of high temporal resolution. This is a
strong indicator that the decrease in brain glucose was not
just a delayed reaction to the hemorrhage but was in some
way related to insulin treatment. The biochemical processes
behind this reaction, however, remain to be elucidated.
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